These studies indicate that at the levels reported, oral l-histidine supplementation is well tolerated and has potential as a safe intervention for long-term use in the management of AD in all age groups.
from: l-Histidine Supplementation in Adults and Young Children with Atopic Dermatitis (Eczema).with no AE being causally related to l-histidine ingestion.
from: l-Histidine Supplementation in Adults and Young Children with Atopic Dermatitis (Eczema).Nine and 8 adverse events (AEs), and 1 and 0 severe AEs were recorded in the l-histidine or placebo groups, respectively, with no AE being causally related to l-histidine ingestion.
from: l-Histidine Supplementation in Adults and Young Children with Atopic Dermatitis (Eczema).Nine and 8 adverse events (AEs), and 1 and 0 severe AEs were recorded in the l-histidine or placebo groups, respectively, with no AE being causally related to l-histidine ingestion.
from: l-Histidine Supplementation in Adults and Young Children with Atopic Dermatitis (Eczema).Nine and 8 adverse events (AEs), and 1 and 0 severe AEs were recorded in the l-histidine or placebo groups, respectively, with no AE being causally related to l-histidine ingestion.
from: l-Histidine Supplementation in Adults and Young Children with Atopic Dermatitis (Eczema).l-histidine reduced AD (34% reduction in SCORing Atopic Dermatitis scores; P < 0.003) after 4 wk.